Changes to the Code
H.R. 4780 · Use Sovereignty To reduce Rx Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
USTRx Act
In committee · step 2 of 5
19 U.S.C. § 2171 Structure, functions, powers, and personnel
3 changes the bill asks for here, 3 carried out
- Carried out:
in the first sentence, by inserting
one Chief Pharmaceutical Trade Negotiator,
afterone Chief Agricultural Negotiator,
; and - Carried out:
by inserting
the Chief Pharmaceutical Trade Negotiator,
afterthe Chief Agricultural Negotiator,
each place it appears. - Carried out:
By adding at the end the following new paragraph:
(7) The principal functions of the Chief Pharmaceutical Trade Negotiator shall be to conduct trade negotiations, enforce trade agreements relating to United States pharmaceutical products, and take appropriate action to address acts, policies, or practices of high-income …
§ 2171(b)–(c)
Start of § 2171 to (b) unchanged ·
(1) The Office shall be headed by the United States Trade Representative who shall be appointed by the President, by and with the advice and consent of the Senate. As an exercise of the rulemaking power of the Senate, any nomination of the United States Trade Representative submitted to the Senate for confirmation, and referred to a committee, shall be referred to the Committee on Finance. The United States Trade Representative shall hold office at the pleasure of the President, shall be entitled to receive the same allowances as a chief of mission, and shall have the rank of Ambassador Extraordinary and Plenipotentiary.
(2) There shall be in the Office three Deputy United States Trade Representatives, one Chief Agricultural Negotiator, [inserted: one Chief Pharmaceutical Trade Negotiator, ]and one Chief Innovation and Intellectual Property Negotiator, who shall be appointed by the President, by and with the advice and consent of the Senate. As an exercise of the rulemaking power of the Senate, any nomination of a Deputy United States Trade Representative, the Chief Agricultural Negotiator, [inserted: the Chief Pharmaceutical Trade Negotiator, ]or the Chief Innovation and Intellectual Property Negotiator submitted to the Senate for its advice and consent, and referred to a committee, shall be referred to the Committee on Finance. Each Deputy United States Trade Representative, the Chief Agricultural Negotiator, [inserted: the Chief Pharmaceutical Trade Negotiator, ]and the Chief Innovation and Intellectual Property Negotiator shall hold office at the pleasure of the President and shall have the rank of Ambassador.
(3) There shall be in the Office one Chief Transparency Officer. The Chief Transparency Officer shall consult with Congress on transparency policy, coordinate transparency in trade negotiations, engage and assist the public, and advise the United States Trade Representative on transparency policy.
(4) A person who has directly represented, aided, or advised a foreign entity (as defined by section 207(f)(3) of title 18) in any trade negotiation, or trade dispute, with the United States may not be appointed as United States Trade Representative or as a Deputy United States Trade Representative.
(5)
(A) When the President submits to the Senate for its advice and consent a nomination of an individual for appointment as a Deputy United States Trade Representative under paragraph (2), the President shall include in that submission information on the country, regional offices, and functions of the Office of the United States Trade Representative with respect to which that individual will have responsibility.
(B) The President shall notify the Committee on Ways and Means of the House of Representatives and the Committee on Finance of the Senate not less than 30 days prior to making any change to the responsibilities of any Deputy United States Trade Representative included in a submission under subparagraph (A), including the reason for that change.
(7) [inserted: The principal functions of the Chief Pharmaceutical Trade Negotiator shall be to conduct trade negotiations, enforce trade agreements relating to United States pharmaceutical products, and take appropriate action to address acts, policies, or practices of high-income countries that have a significant adverse impact on the ability of United States pharmaceutical manufacturers to enjoy full market access. The Chief Pharmaceutical Trade Negotiator shall be a vigorous advocate on behalf of United States manufacturers and consumers of pharmaceutical products and shall perform such other functions as the United States Trade Representative may direct. In carrying out such duties, the Chief Pharmaceutical Negotiator shall, as appropriate, consult or coordinate with the Chief Intellectual Property Negotiator.]
(c) Duties of United States Trade Representative and Deputy United States Trade Representatives
(1) The United States Trade Representative shall—
Rest of § 2171 unchanged ·